Perspective Therapeutics, Inc.

CATX · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
6/30/2022
Operating Activities
Net Income-$79-$47-$15-$7
Dep. & Amort.$2$1$0$0
Deferred Tax-$2-$3-$2$0
Stock-Based Comp.$5$4$1$1
Change in WC$0$2$0-$2
Other Non-Cash$55$5$0$0
Operating Cash Flow-$18-$37-$12-$8
Investing Activities
PP&E Inv.-$54-$1-$0-$0
Net Acquisitions$0$3$0$0
Inv. Purchases-$244$0$0$0
Inv. Sales/Matur.$0$23$0$0
Other Inv. Act.$79-$0-$57-$0
Investing Cash Flow-$219$24-$58-$0
Financing Activities
Debt Repay.$0-$0$0$0
Stock Issued$276$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$289$0$0$0
Financing Cash Flow$289$1$0$0
Forex Effect$0$0$62$0
Net Chg. in Cash$52-$47$0-$8
Supplemental Information
Beg. Cash$9$21$56$64
End Cash$62$9$56$56
Free Cash Flow-$73-$38-$12-$8
Perspective Therapeutics, Inc. (CATX) Financial Statements & Key Stats | AlphaPilot